The systematic exploitation of the body’s natural immune response to fight aggressive illnesses (immunotherapy)—including cancers (oncology)—is gaining popularity. The market for large molecule drugs, also known as biologics, is expected to reach $399 billion by 2025.

In this eBook, we analyse five drugs that could help us fight cancer in new and far more effective ways, with a large focus on monoclonal antibodies: 

  1. Avelumab
  2. Tositumomab
  3. Technetium Tc-99m Arcitumomab
  4. Olaratumab
  5. Gemtuzumab Ozogamicin

You'll learn which companies, aside from primary manufacturers, are interested in these drugs—and which drugs hold unique opportunities for commercialisation. This eBook also demonstrates a new and far more effective way of running BLAST analysis on protein sequences. 

Simply fill out the form on the right to download the full ebook for free. 

Immuno-oncology protein sequences eBook cover